Stiffness of the large arteries in individuals with and without Down syndrome

Vascular Health and Risk Management

Volumn 7, Issue 1, 2011, Pages 375-381

  Rodrigues, Anabel N ^a,b   Cesar Coelho, Luan ^a   Goncalves, Washington L S ^a,b   Alves Gouvea, Sonia ^b   José Rossi, Maria ^a   Vasconcellos, ^a   Cunha, Roberto S ^b   Abreu, Glaucia R ^b  

^a School of Medicine University Center of Espírito Santo   (Brazil)

^b FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

Aging; Arterial stiffness; Down syndrome; Pulse wave velocity

Indexed keywords

ADOLESCENT; ADULT; AGE; AORTA; ARTERY; ARTICLE; BLOOD FLOW; BLOOD PRESSURE; BRAZIL; CAROTID ARTERY; CASE CONTROL STUDY; DOWN SYNDROME; ELASTICITY; FEMALE; FEMORAL ARTERY; HUMAN; MALE; PATHOPHYSIOLOGY; PULSATILE FLOW; STATISTICAL MODEL; TIME;

ADOLESCENT; ADULT; AGE FACTORS; AORTA; ARTERIES; BLOOD PRESSURE; BRAZIL; CAROTID ARTERIES; CASE-CONTROL STUDIES; DOWN SYNDROME; ELASTICITY; FEMALE; FEMORAL ARTERY; HUMANS; LINEAR MODELS; MALE; PULSATILE FLOW; REGIONAL BLOOD FLOW; TIME FACTORS; YOUNG ADULT;

EID: 80055097522     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/VHRM.S21273     Document Type: Article

References (43)

1. Safar ME, Toto-Moukou JJ, Bouthier JA, et al. Arterial dynamics, cardiac hypertrophy, and antihypertensive treatment. Circulation. 1987;75: 156-161.
2. Safar ME. Therapeutic trials and large arteries in hypertension. Am Heart J. 1988;115:702-710.
3. Safar ME, London G, Asmar RG, et al. Recent advances on large arteries in hypertension. Hypertension. 1998;32:156-161.
4. Blacher J, Asmar R, Djane S, et al. Aortic pulse velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension. 1999;33: 1111-1117.
5. Lehmann ED. Clinical value of aortic pulse-wave velocity measurement. Lancet. 1999;354:528-529.
6. Hamet P, Thorin-Trescasesn N, Moreau P, et al. Excess growth and apoptosis. Is hypertension a case of accelerated aging of cardiovascular cells? Hypertension. 2001;37:760-766.
7. Von Zglinicki T. Telomeres: Influencing the rate of aging. Ann N Y Acad Sci. 1998;854:318-327.
8. Reddel RR. A reassessment of the telomere hypothesis of senescence. BioEssays. 1998;20:977-984.
9. Cunha RS, Benetos A, Laurent S, Safar ME, Asmar RG. Distension capacity of the carotid artery and ambulatory blood pressure monitoring: Effects of age and hypertension. Am J Hypertens. 1995;8:343-352.
10. Smulyan H, Marchais SJ, Pannier B, et al. Influence of body height on pulsatile arterial hemodynamic data. J Am Coll Cardiol. 1998;31: 1103-1109.
11. Avolio A, Jones D, Tafazzoli-Shadpour M. Quantification of alterations in structure and function of elastin in the arterial media. Hypertension. 1998;32:170-175.
12. Cunha RS, Dabire H, Bezie Y, et al. Mechanical stress of the carotid artery at the early phase of spontaneous hypertension in rats. Hypertension. 1997;29:992-998.
13. Lakatta EG. Arterial pressure and aging. Int J Cardiol. 1989;25: S81-S89.
14. Nakamura E, Tanaka S. Biological ages of adult men and women with Down's syndrome and its changes with aging. Mech Ageing Dev. 1998;105: 89-103.
15. Comfort A. Test-battery to measure ageing-rate in man. Lancet. 1969;27:1411-1415.
16. Hofecker G, Skalicky M, Kment A, et al. Models of the biological age of the rat. I. A factor model of age parameters. Mech Ageing Dev. 1980;14:345-359.
17. Haynes A, Batshaw M. Down syndrome. Pediatr Clin North Am. 1993;40:523-535.
18. Asmar R, Benetos A, Topouchian J, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Hypertension. 1995;26:485-490.
19. Murdoch JC, Roger JCH, Rao SS, et al. Down syndrome: An atheroma free model? Br Med J. 1977;2:226-228.
20. Morrison RA, McGrath A, Davidson G, et al. Low blood pressure in Down's syndrome, a link with Alzheimer's disease? Hypertension. 1996;28:569-575.
21. Yang Q, Rasmussem SA, Friedman JM, et al. Mortality associated with Down's syndrome in the USA from 1983 to 1997: A population-based study. Lancet. 2002;359:1019-1025.
22. Yla-Herttuala S, Luoma J, Nikkari T, et al. Down syndrome and atherosclerosis. Atherosclerosis. 1989;76:269-272.
23. Goyal P, Singh R, Yadav A, et al. Dyslipidemia and superoxide dismutase activity in children with Down syndrome. J Nepal Pediatr Soc. 2010;30:160-163.
24. Bortolotto LA, Blacher J, Kondo T, et al. Assessment of vascular aging and atherosclerosis in hypertensive subjects: Second derivative of photoplethysmogram versus pulse wave velocity. Am J Hypertens. 2000;13:165-171.
25. Lehman ED. Noninvasive measurements of aortic stiffness: Methodological considerations. Pathol Biol (Paris). 1999;47:716-730. French.
26. Ganong WF. Review of Medical Physiology. 17th ed. East Norwalk, CT: Appleton and Lange; 1995.
27. Osiewacz HD, Hamann A. DNA reorganization and biological aging. A review. Biochemistry (Mosc). 1997;62:1275-1284.
28. Folkow B, Svanborg A. Physiology of cardiovascular aging. Physiol Rev.1993;73:725-764.
29. O'Rourke MF, Mancia G. Arterial stiffness. J Hypertens. 1999; 17:1-4.
30. Arnett DK, Evans GW, Riley WA. Arterial stiffness: A new cardiovascular risk factor? Am J Epidemiol. 1994;140:669-682.
31. Avoilo AP, Fa-quan D, Wei-Quiang L, et al. Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension comparison between urban and rural communities in China. Circulation. 1985;71:202-210.
32. Bland J, Altman G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;88: 307-322.
33. Benetos A, Topouchian J, Richard S, et al. Influence of angiotensin II type 1 receptor polymorphism on aortic stiffness in never treated hypertensive patients. Hypertension. 1995;26:44-47.
34. Benetos A, Gautier S, Richard S. Influence of angiotensin II type 1 receptor gene polymorphism on aortic stiffness in normotensive and hypertensive patients. Circulation. 1996;94:698-703.
35. London GM, Guerin AP, Pannier B, et al. Influence of sex on arterial hemodynamics and blood pressure. Role of body-height. Hypertension. 1995;26:514-519.
36. Toto-Moukouo JJ, Achimastos A, Asmar RG, et al. Pulse wave velocity in patients with obesity and hypertension. Am Heart J. 1986;1120: 136-140.
37. Sharav T, Bowman T. Dietary practices, physical activity, and body-mass index in a selected population of Down syndrome children and their siblings. Clin Pediatr. 1992;31:341-344.
38. Avolio A. Genetic and environmental factors in the function and structure of the arterial wall. Hypertension. 1995;26:34-37.
39. Benetos A, Rudnichi A, Safar M, Guize L. Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension. 1999;32:560-564.
40. Morcet JF, Safar M, Thomas F, et al. Associations between rate and other risk factors in a large French population. J Hypertens. 1999;17: 1671-1676.
41. London GM, Safar ME. Arterial wall remodeling and stiffness in hypertension: Heterogeneous aspects. Clin Exp Pharmacol Physiol. 1996;23:S1-S5.
42. Richards BW, Enver F. Blood pressure in Down's syndrome. J Ment Defic Res. 1979;23:123-133.
43. Russo MA, Pacileo G, Marino B, et al. Echocardiographic evaluation of left ventricular systolic function in the Down syndrome. Am J Cardiol. 1998;81:1215-1217.